FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383498030> ?p ?o ?g. }

• W4383498030 endingPage "110624" @default.
• W4383498030 startingPage "110624" @default.
• W4383498030 abstract "Bladder cancer (BCa) is a urinary tumor with limited treatment options and high mortality. Liensinine (LIEN), a natural bisbenzylisoquinoline alkaloid, has shown excellent anti-tumor effects in numerous preclinical studies. However, the anti-BCa effect of LIEN remains unclear. To the best of our knowledge, this is the first study to investigate the molecular mechanism of LIEN in the management of BCa. First, we identified the treatment-related targets of BCa; those that repeatedly occur in more than two databases, including GeneCards, Online Mendelian Inheritance in Man, DisGeNET, Therapeutic Target Database, and Drugbank. The SwissTarget database was used to screen LIEN-related targets, and those with a probability >0 were possible LIEN targets. The prospective targets of LIEN in the treatment of BCa were then determined using a Venn diagram. Second, we discovered that the PI3K/AKT pathway and senescence mediated the anti-BCa action of LIEN by using GO and KEGG enrichment analysis to explore the function of LIEN therapeutic targets. A protein-protein interaction network was created using the String website, and six algorithms of the CytoHubba plug-in were then used in Cytoscape to assess the core targets of LIEN for the therapy of BCa. The outcomes of molecular docking and dynamics simulation demonstrated that CDK2 and CDK4 proteins were the direct targets of LIEN in the management of BCa, among which CDK2 was more stable in binding to LIEN than CDK4. Finally, in vitro experiments showed that LIEN inhibited the activity and proliferation of T24 cells. The expression of p-/AKT, CDK2, and CDK4 proteins progressively decreased, while the expression and fluorescence intensity of the senescence-related protein, γH2AX, gradually increased with increasing LIEN concentration in T24 cells. Therefore, our data suggest that LIEN may promote senescence and inhibit proliferation by inhibiting the CDK2/4 and PI3K/AKT pathways in BCa." @default.
• W4383498030 created "2023-07-08" @default.
• W4383498030 creator A5002425471 @default.
• W4383498030 creator A5013573710 @default.
• W4383498030 creator A5029439647 @default.
• W4383498030 creator A5033560825 @default.
• W4383498030 creator A5039366205 @default.
• W4383498030 creator A5060310279 @default.
• W4383498030 creator A5064970901 @default.
• W4383498030 creator A5066756187 @default.
• W4383498030 creator A5067645019 @default.
• W4383498030 creator A5092420110 @default.
• W4383498030 date "2023-09-01" @default.
• W4383498030 modified "2023-10-09" @default.
• W4383498030 title "CDK2 and CDK4 targeted liensinine inhibits the growth of bladder cancer T24 cells" @default.
• W4383498030 cites W1674751464 @default.
• W4383498030 cites W2043950247 @default.
• W4383498030 cites W2054182657 @default.
• W4383498030 cites W2090672107 @default.
• W4383498030 cites W2135927648 @default.
• W4383498030 cites W2151781453 @default.
• W4383498030 cites W2152455106 @default.
• W4383498030 cites W2398711217 @default.
• W4383498030 cites W2508173956 @default.
• W4383498030 cites W2538113786 @default.
• W4383498030 cites W2593709873 @default.
• W4383498030 cites W2617799874 @default.
• W4383498030 cites W2783121990 @default.
• W4383498030 cites W2888182234 @default.
• W4383498030 cites W2890102889 @default.
• W4383498030 cites W2901527454 @default.
• W4383498030 cites W2944684797 @default.
• W4383498030 cites W2955205791 @default.
• W4383498030 cites W2970526215 @default.
• W4383498030 cites W2982689981 @default.
• W4383498030 cites W3017609100 @default.
• W4383498030 cites W3081067557 @default.
• W4383498030 cites W3092169233 @default.
• W4383498030 cites W3106785508 @default.
• W4383498030 cites W3108775243 @default.
• W4383498030 cites W3128646645 @default.
• W4383498030 cites W3162538759 @default.
• W4383498030 cites W3210331473 @default.
• W4383498030 cites W4200045218 @default.
• W4383498030 cites W4205194412 @default.
• W4383498030 cites W4210418395 @default.
• W4383498030 cites W4211101637 @default.
• W4383498030 cites W4211187110 @default.
• W4383498030 cites W4221042947 @default.
• W4383498030 cites W4226302947 @default.
• W4383498030 cites W4280511453 @default.
• W4383498030 cites W4283313052 @default.
• W4383498030 cites W4294844195 @default.
• W4383498030 cites W4297102182 @default.
• W4383498030 cites W4308253982 @default.
• W4383498030 cites W4310726927 @default.
• W4383498030 doi "https://doi.org/10.1016/j.cbi.2023.110624" @default.
• W4383498030 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37423554" @default.
• W4383498030 hasPublicationYear "2023" @default.
• W4383498030 type Work @default.
• W4383498030 citedByCount "0" @default.
• W4383498030 crossrefType "journal-article" @default.
• W4383498030 hasAuthorship W4383498030A5002425471 @default.
• W4383498030 hasAuthorship W4383498030A5013573710 @default.
• W4383498030 hasAuthorship W4383498030A5029439647 @default.
• W4383498030 hasAuthorship W4383498030A5033560825 @default.
• W4383498030 hasAuthorship W4383498030A5039366205 @default.
• W4383498030 hasAuthorship W4383498030A5060310279 @default.
• W4383498030 hasAuthorship W4383498030A5064970901 @default.
• W4383498030 hasAuthorship W4383498030A5066756187 @default.
• W4383498030 hasAuthorship W4383498030A5067645019 @default.
• W4383498030 hasAuthorship W4383498030A5092420110 @default.
• W4383498030 hasConcept C10138342 @default.
• W4383498030 hasConcept C104317684 @default.
• W4383498030 hasConcept C10679952 @default.
• W4383498030 hasConcept C150194340 @default.
• W4383498030 hasConcept C152724338 @default.
• W4383498030 hasConcept C155261790 @default.
• W4383498030 hasConcept C162324750 @default.
• W4383498030 hasConcept C185592680 @default.
• W4383498030 hasConcept C198004926 @default.
• W4383498030 hasConcept C2780035454 @default.
• W4383498030 hasConcept C2987395477 @default.
• W4383498030 hasConcept C55493867 @default.
• W4383498030 hasConcept C70721500 @default.
• W4383498030 hasConcept C86803240 @default.
• W4383498030 hasConcept C98274493 @default.
• W4383498030 hasConceptScore W4383498030C10138342 @default.
• W4383498030 hasConceptScore W4383498030C104317684 @default.
• W4383498030 hasConceptScore W4383498030C10679952 @default.
• W4383498030 hasConceptScore W4383498030C150194340 @default.
• W4383498030 hasConceptScore W4383498030C152724338 @default.
• W4383498030 hasConceptScore W4383498030C155261790 @default.
• W4383498030 hasConceptScore W4383498030C162324750 @default.
• W4383498030 hasConceptScore W4383498030C185592680 @default.
• W4383498030 hasConceptScore W4383498030C198004926 @default.
• W4383498030 hasConceptScore W4383498030C2780035454 @default.
• W4383498030 hasConceptScore W4383498030C2987395477 @default.

• next